-
Potential buyers size up Novartis site as layoffs loom for 400 workers
fiercepharma
September 08, 2019
The clock is ticking down for the 400 workers at a Novartis plant which was put on the block last year as the company cuts costs to finance new therapies. There is some hope, however, with half a dozen companies taking a look at the U.K. site.
-
Boehringer Ingelheim chops 295 jobs in France but vows $380M in animal health investments
fiercepharma
December 12, 2018
When German pharma Boehringer Ingelheim completed a $12.5 billion asset swap with France’s Sanofi in 2016, BI traded its consumer health business for Sanofi’s veterinary unit and agreed
-
Akcea lays off 10% of staff following volanesorsen rejection
fiercebiotech
September 10, 2018
Akcea had built its headcount up to 270 in anticipation of bringing volanesorsen to market.
-
EMA to cut activities as it forecasts loss of 30% of staff
pharmafile
August 03, 2018
The European Medicines Agency is set to enact temporary cuts in activities as it prepares for significant disruption in the wake of Brexit.
-
SoCal's Vical Terminates 54% of Workforce to Focus Resources on Two Clinical Programs
biospace
February 01, 2018
Following a failed Phase III vaccine for stem cell transplant recipients last week, San Diego-based Vical Incorporated is slashing 54 percent of its employees and focusing its remaining resources on two mid-stage candidates.
-
Teva Announces Philadelphia-Area Layoffs
americanpharmaceuticacreview
January 23, 2018
Teva Pharmaceuticals will lay off 208 people this year at their Pennsylvania-based locations, according to notices filed with the Pennsylvania Department of Labor and Industry.
-
Jobs Lost as Cellectar Biosciences Shutters Manufacturing Operations
biospace
January 10, 2018
Cellectar Biosciences is closing its manufacturing operations and contracting them out. As a result, it expects to lay off six of its 16 employees.
-
Allergan to cut 1,000+ Jobs
biospace
January 05, 2018
Allergan will cut 1,000 jobs, about 5% of the total workforce
-
The Numbers Are In: Bay Area's Depomed Reveals 328 Job Cuts in WARN Notice
biospace
January 02, 2018
Depomed filed notice with the State of California, indicating it planned to lay off 328 staffers starting Feb. 4, 2018 through the end of 2018.
-
TearLab to Cut More Jobs
biospace
December 28, 2017
TearLab Corporation (OTC:TEAR) is looking to keep its customer base and reduce the company’s cash burn rate with a new business model that will result in people losing their jobs, according to regulatory filings.